Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation response in schizophrenia and prostaglandin E1.

H Kaiya, H Imai, Y Muramatsu

    Psychiatry Research
    |August 1, 1983
    PubMed
    Summary

    Schizophrenia patients show altered platelet aggregation. Neuroleptic medication may normalize these responses, correlating with clinical improvement in platelet aggregation to arachidonic acid.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Differential Cross Section and Photon-Beam Asymmetry for the γ[over →]p → π^{-}Δ^{++}(1232) Reaction at Forward π^{-} Angles for E_{γ}=1.5-2.95  GeV.

    Physical review letters·2018
    Same author

    Interference Effect between ϕ and Λ(1520) Production Channels in the γp→K^{+}K^{-}p Reaction near Threshold.

    Physical review letters·2016
    Same author

    Molecular dynamics analysis on wetting and interfacial properties of water-alcohol mixture droplets on a solid surface.

    The Journal of chemical physics·2015
    Same author

    Molecular dynamics analysis of multiphase interfaces based on in situ extraction of the pressure distribution of a liquid droplet on a solid surface.

    The Journal of chemical physics·2014
    Same author

    Purification and genetic control of α-pheromone-inactivating glycoproteins in the yeast Saccharomyces cerevisiae.

    Current genetics·2013
    Same author

    Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination.

    Cell death & disease·2013

    Area of Science:

    • Neuroscience
    • Hematology
    • Psychiatry

    Background:

    • Platelet aggregation is crucial for hemostasis.
    • Aberrant platelet function has been observed in psychiatric disorders.
    • Understanding platelet behavior in schizophrenia may offer therapeutic insights.

    Purpose of the Study:

    • To investigate platelet aggregation responses in schizophrenic patients.
    • To examine the effects of neuroleptic medication on platelet function.
    • To explore correlations between platelet aggregation and clinical improvement.

    Main Methods:

    • Platelet aggregation was measured using various stimulants (epinephrine, arachidonic acid, adenosine diphosphate).
    • Comparisons were made between unmedicated schizophrenic patients, medicated patients, and healthy controls.

    Related Experiment Videos

  • The inhibitory effect of prostaglandin E1 on adenosine diphosphate-induced aggregation was assessed.

    • Main Results:

    • Unmedicated schizophrenic patients exhibited decreased platelet aggregation in response to epinephrine.
    • A significant reduction in the inhibitory effect of prostaglandin E1 on adenosine diphosphate-induced aggregation was observed in unmedicated patients.
    • Clinical improvement in medicated patients correlated with increased platelet aggregation response to arachidonic acid.

    Conclusions:

    • Schizophrenia is associated with specific alterations in platelet aggregation.
    • Neuroleptic medication may partially normalize aberrant platelet responses.
    • Platelet aggregation changes, particularly to arachidonic acid, may serve as a biomarker for treatment response in schizophrenia.